Insider · CIK 0001486345
Richard P. Blumberg
Files at GTHP (GUIDED THERAPEUTICS INC). First filing -, latest -.
In brief
Richard P. Blumberg files SEC Form 4 as director and 10% owner at GTHP (GUIDED THERAPEUTICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard P. Blumberg has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | MOption exercise Common Stock | +1,000,000 | - | - | 8,924,180 | May 5, 2026 |
| Mar 26, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Common Stock | +56,093 | - | - | 8,980,273 | May 5, 2026 |
| Mar 26, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Preferred Series F Stock | -260 | - | - | 0 | May 5, 2026 |
| Mar 26, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Common Stock | +1,040,000 | - | - | 10,020,273 | May 5, 2026 |
| Mar 26, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Common Stock | +19,038 | - | - | 10,039,311 | May 5, 2026 |
| Mar 26, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Preferred Series F-2 Stock | -88 | - | - | 0 | May 5, 2026 |
| Mar 26, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Common Stock | +352,000 | - | - | 10,391,311 | May 5, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | DDisposition to issuer Warrantsderivative | -1,000,000 | - | - | 0 | May 5, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | AGrant or award Warrantsderivative | +1,000,000 | - | - | 1,000,000 | May 5, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | DDisposition to issuer Warrantsderivative | -1,000,000 | - | - | 0 | May 5, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | AGrant or award Warrantsderivative | +1,000,000 | - | - | 1,000,000 | May 5, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | MOption exercise Warrantsderivative | -1,000,000 | $0.20 | $200k | 0 | May 5, 2026 |
| Mar 1, 2026 | GTHP GUIDED THERAPEUTICS INC | HExpiration of long derivative Warrantsderivative | -900,000 | $0.30 | $270k | 2,700,000 | May 5, 2026 |
| Mar 10, 2026 | GTHP GUIDED THERAPEUTICS INC | AGrant or award Stock Optionsderivative | +110,000 | $0.00 | $0 | 110,000 | May 5, 2026 |
| Apr 10, 2025 | GTHP GUIDED THERAPEUTICS INC | JOther Common Stock | +165,481 | - | - | 6,855,206 | Sep 5, 2025 |
| Apr 10, 2025 | GTHP GUIDED THERAPEUTICS INC | JOther Common Stock | +55,853 | - | - | 6,911,059 | Sep 5, 2025 |
| Aug 21, 2025 | GTHP GUIDED THERAPEUTICS INC | JOther Common Stock | +81,121 | - | - | 6,992,180 | Sep 5, 2025 |
| Aug 21, 2025 | GTHP GUIDED THERAPEUTICS INC | JOther Preferred Series E Stock | -233 | - | - | 0 | Sep 5, 2025 |
| Aug 21, 2025 | GTHP GUIDED THERAPEUTICS INC | JOther Common Stock | +932,000 | - | - | 7,924,180 | Sep 5, 2025 |
| Jun 3, 2025 | GTHP GUIDED THERAPEUTICS INC | AGrant or award Stock Optionsderivative | +110,000 | $0.00 | $0 | 110,000 | Sep 5, 2025 |
| Oct 14, 2024 | GTHP GUIDED THERAPEUTICS INC | JOther Common Stock | +400,000 | - | - | 6,689,725 | Oct 24, 2024 |
| Sep 1, 2024 | GTHP GUIDED THERAPEUTICS INC | JOther Warrantsderivative | +900,000 | - | - | 3,600,000 | Oct 24, 2024 |
| Dec 1, 2023 | GTHP GUIDED THERAPEUTICS INC | XIn-the-money exercise Common stock | +1,642,500 | - | - | 5,565,357 | Dec 8, 2023 |
| Nov 16, 2023 | GTHP GUIDED THERAPEUTICS INC | JOther Warrantsderivative | -875,000 | - | - | 0 | Dec 8, 2023 |
| Nov 16, 2023 | GTHP GUIDED THERAPEUTICS INC | JOther Warrantsderivative | -950,000 | - | - | 0 | Dec 8, 2023 |
| Nov 16, 2023 | GTHP GUIDED THERAPEUTICS INC | JOther Warrantsderivative | +1,642,500 | - | - | 1,642,500 | Dec 8, 2023 |
| Dec 1, 2023 | GTHP GUIDED THERAPEUTICS INC | XIn-the-money exercise Warrantsderivative | -1,642,500 | - | - | 0 | Dec 8, 2023 |
Questions about Richard P. Blumberg
Answered from the filings on this page, as of the latest one.
Is Richard P. Blumberg buying or selling?
Richard P. Blumberg has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard P. Blumberg's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard P. Blumberg has 0.
Where does Richard P. Blumberg file Form 4?
Richard P. Blumberg has filed Form 4 at GTHP (GUIDED THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.